Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TBPH

Theravance Biopharma (TBPH)

Theravance Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TBPH
DateTimeSourceHeadlineSymbolCompany
07/03/202522:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TBPHTheravance Biopharma Inc
05/03/202510:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
05/03/202510:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
05/03/202510:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
05/03/202510:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
27/02/202508:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
27/02/202508:05PR Newswire (US)Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:TBPHTheravance Biopharma Inc
25/02/202511:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
25/02/202511:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
25/02/202511:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
25/02/202511:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
20/02/202522:00PR Newswire (US)Theravance Biopharma to Participate in an Upcoming Investor ConferenceNASDAQ:TBPHTheravance Biopharma Inc
12/02/202522:00PR Newswire (US)Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025NASDAQ:TBPHTheravance Biopharma Inc
05/02/202522:00PR Newswire (US)Theravance Biopharma to Participate in an Upcoming Investor ConferenceNASDAQ:TBPHTheravance Biopharma Inc
24/01/202510:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
22/01/202508:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TBPHTheravance Biopharma Inc
17/12/202422:00PR Newswire (US)Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare ConferenceNASDAQ:TBPHTheravance Biopharma Inc
23/11/202410:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
23/11/202410:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
23/11/202410:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
23/11/202410:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
20/11/202422:00PR Newswire (US)Theravance Biopharma to Participate in an Upcoming Investor ConferenceNASDAQ:TBPHTheravance Biopharma Inc
15/11/202401:53Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TBPHTheravance Biopharma Inc
14/11/202422:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBPHTheravance Biopharma Inc
14/11/202412:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
13/11/202408:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
13/11/202408:05PR Newswire (US)Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder ValueNASDAQ:TBPHTheravance Biopharma Inc
25/10/202407:44Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TBPHTheravance Biopharma Inc
24/10/202421:00PR Newswire (US)Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024NASDAQ:TBPHTheravance Biopharma Inc
19/10/202400:00PR Newswire (US)Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary DiseaseNASDAQ:TBPHTheravance Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:TBPH